NNC0491-6075

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0491-6075, covering 2025-05-04 to 2025-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood [Phase 1]

See pricing